We unify expert intelligence and automation to accelerate every phase of drug development—from discovery through IND and beyond.
DAO of Drugs was founded on a bold vision:To eliminate friction across the entire drug development lifecycle, not by working around bottlenecks but by transforming them. Through agentic native innovation, we reimagined how drug development should work. Our intelligent systems empower AI driven agents to collaborate seamlessly across data, decisions, and stakeholders, dramatically reducing time, cost, and complexity while accelerating clarity, precision, and scale.
Reengineering the BottlenecksWhat once stalled progress—identifying the right indications, navigating regulatory hurdles, and executing clinical trials—became the blueprint for our solution.
Rather than bypassing these challenges, we built a platform designed to confront and resolve them at the source. By leveraging specialized agents that think, adapt, and act in unison, Dao of Drugs delivers a smarter, faster path to breakthrough therapies, redefining what’s possible in biopharma.
Madhav Reddy
Co-Founder
Over 20 years of driving innovation and pioneering technologies in emerging markets including founding Maya Clinicals and Senior Business Development roles at AI startups including Tempus and Nucleai.ai Proven expertise in accelerating growth and delivering groundbreaking solutions for Large Pharma and Biotech, along with securing strategic wins at global CROs like IQVIA and Parexel. Recognized for disrupting markets and capturing customers from entrenched incumbents. Key role in the launch of custom semiconductors at LSI Logic and spearheaded optical networking innovations at Nayna Networks.
Manish Vipani
Co-Founder
Manish is a transformational leader with deep expertise in healthcare, platform development, and AI-driven innovation. He has led large-scale initiatives at Wells Fargo and Kaiser Permanente, including the implementation of electronic medical records and the modernization of enterprise platforms.Recognized as a"50 Rising Star in IT," Manish brings strategic vision and execution to Dao of Drugs' mission to revolutionize drug development.
Jennifer Clauson
VP of Strategic Partnerships
Jennifer is a multi-faceted executive leader with a track record of delivering effective innovation partnerships, particularly in the application of AI in clinical trials. She served as VP of Research Partnerships at Dyania Health. Director of Clinical Trials Operations at Tempus, System Director of Research at AMITA Health. Jennifer's agility in stakeholder alignment, and ability to blend vision with process rigor and quality, make her uniquely positioned to accelerate collaboration for Dao of Drugs.
Nancy Wilcox
Head of Clinical Operations
Over 25 years in clinical operations and global trial management.Successful completion of 6 NDA packages for AIDS, anti-infective, topical dermatology /oncology (AK), and pain management trials. Participated in shortest NDA in FDA history; 36 months. The last NDA was completed in 10 months. Deep knowledge and expertise in global clinical trial project management, head of clinical operations at large Pharma's such as Pharma C, Abbott, Celgene, managed trials at global sites in India, North America, and Europe
